title: [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
abstract: OBJECTIVE
  To assess the quality of life (QOL) and satisfaction (SF) in patients with type 1 diabetes mellitus (T1DM) treated with continuous subcutaneous insulin infusion (CSII) compared with multiple daily insulin injections (MDI).
  
  
  METHODS
  A descriptive study was conducted to assess the QOL and SF of 68 patients on CSII or MDI treatment (1:2). The instruments used were, the Spanish version of the Diabetes Quality of Life (EsDQOL) specific for diabetes related QOL, SF-36 for general QOL, and the Diabetes Treatment Satisfaction Questionnaire (DTSQ) for SF evaluation.
  
  
  RESULTS
  The EsDQOL scores for patients on CSII therapy were similar to those treated with MDI (87.20±21.11 vs 86.83±20.7, P=.86), with lower scores in the SF-36 questionnaire (66.91±15.76 vs 75.90±14.56, P=.03) except in Health Transition section, where patients treated with CSII showed higher scores (68.75±19.66 vs 57.93±17.18, p=.02). The values obtained in the DTSQ questionnaire were higher in CSII patients compared with the MDI group in last weeks (31.50±4.66 vs 27.83±6.06, p=.01) and last three months periods (13.2±6.73 vs 8.77±7.40, p=.01).
  
  
  CONCLUSIONS
  Patients with T1DM on CSII therapy showed a poorer global QOL, although they felt more satisfied with their treatment than those treated with MDI. No differences in diabetes related QOL were detected between groups.
authors.affiliation: Sección de Endocrinología y Nutrición, Hospital General Universitario de Ciudad Real, Servicio de Salud de Castilla-La Mancha SESCAM, Ciudad Real, España. lozano_montse@hotmail.com
authors.forename: Monserrat
authors.initials: M
authors.lastname: Lozano-Serrano
authors.forename: José Alberto
authors.initials: JA
authors.lastname: García-Seco
authors.forename: Fernando
authors.initials: F
authors.lastname: García-Seco
authors.forename: María Concepción
authors.initials: MC
authors.lastname: Lozano-Hernández
authors.forename: Ángela María
authors.initials: ÁM
authors.lastname: Seco-Segura
authors.forename: Jesús
authors.initials: J
authors.lastname: Moreno-Fernández
authors.forename: Pedro Antonio
authors.initials: PA
authors.lastname: Muñoz-Cazallas
authors.forename: Carmen
authors.initials: C
authors.lastname: Ferreiro-Vicario
authors.forename: Miguel Aguirre
authors.initials: MA
authors.lastname: Sánchez-Covisa
mesh_terms: D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011788:Quality of Life; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin